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Abstract
Humans are exposed to a large number of environmental chemicals in their daily life, many
of which are readily detectable in blood or urine. It remains uncertain if these chemicals can
cause adverse health effects when present together at low doses. In this study we have
tested whether a mixture of 27 chemicals administered orally to juvenile male rats for three
months could leave a pathophysiological footprint. The mixture contained metals, perfluori-
nated compounds, PCB, dioxins, pesticides, heterocyclic amines, phthalate, PAHs and oth-
ers, with a combined dose of 0.16 (Low dose), 0.47 (Mid dose) or 1.6 (High dose) mg/kg bw/
day. The lowest dose was designed with the aim of obtaining plasma or urine concentra-
tions in rats at levels approaching those observed in humans. Some single congeners were
administered at doses representative of combined doses for chemical groups. With this
baseline, we found effects on weight, histology and gene expression in the liver, as well as
changes to the blood plasma metabolome in all exposure groups, including low-dose. Addi-
tional adverse effects were observed in the higher dosed groups, including enlarged kid-
neys and alterations to the metabolome. No significant effects on reproductive parameters
were observed.
Introduction
Humans are continuously exposed to a large number of chemicals from various sources,
including consumables, cosmetics, fabrics and polluted air. Most of these chemicals are typi-
cally present in our bodies at very low concentrations and usually deemed safe. ‘Safe levels’ of
chemical exposure, however, are normally based on the toxicological profile of one chemical at
a time. What happens when a substantial number of chemicals are present simultaneously, but
still at very low levels, remains less understood and could potentially have unforeseen conse-
quences for humans and the environment.
PLOSONE | DOI:10.1371/journal.pone.0162027 September 6, 2016 1 / 22
a11111
OPEN ACCESS
Citation: Hadrup N, Svingen T, Mandrup K, Skov K,
Pedersen M, Frederiksen H, et al. (2016) Juvenile
Male Rats Exposed to a Low-Dose Mixture of
Twenty-Seven Environmental Chemicals Display
Adverse Health Effects. PLoS ONE 11(9): e0162027.
doi:10.1371/journal.pone.0162027
Editor: Cheryl S. Rosenfeld, University of Missouri
Columbia, UNITED STATES
Received: May 24, 2016
Accepted: August 16, 2016
Published: September 6, 2016
Copyright: © 2016 Hadrup et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by The Ministry
of Food, Agriculture and Fisheries of Denmark and
the Danish Veterinary and Food Administration and
EDMaRC - International Center for Research and
Research Training in Endocrine Disrupting Effects on
Male Reproduction and Child Health. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
In vivo studies designed to determine potential effects of large chemical mixtures, particu-
larly at low doses, are few. Hence, more in vivomixture studies would greatly aid in our under-
standing of complex chemical interactions in intact biological systems. But we can gain some
early insights from studies already performed. For instance, we previously showed that per-
fluorononanoic acid (PFNA) at a high-end human exposure range can exert mixture effects in
rats when given in combination with a 14-chemical mixture [1]. Further examples include:
increased lytic activity by natural killer cells following low level exposure to 18 persistent con-
taminants [2]; increased prostate inflammation in rats with an atrazine metabolite mixture at a
dose of 0.09 mg/kg bw/day [3]; changes to blood cell counts in mice following exposure to a
mixture of six pesticides at doses derived from the acceptable daily intake levels in humans [4];
decreased red blood cell count and hemoglobin concentrations in mice after exposure to a mix-
ture consisting of 4, 5 and 8 μg/kg bw/day of atrazine, endosulfan and chlorpyrifos, respectively
[5], and; additive effects of thyroid disrupters in rats exposed at a dose corresponding to the
environmental background [6]. These studies not only show low-dose mixture effects of chem-
icals when present together, but also highlights the importance of taking putative mixture
effects into account when extrapolating safe levels of exposure to bioavailable chemicals.
Mixture studies have typically involved simultaneous exposure to closely related chemicals,
for instance pesticides, thyroid disruptors or atrazine metabolites. In a human context, however,
the chemical burden is far more complex and includes chemicals from vastly different sources
and classifications. Therefore, we designed a low-dose mixture study in juvenile male rats using
27 chemicals relevant for human exposure. We chose to expose juvenile rats since this life stage
represents a sensitive period of male reproduction. Although the male offspring are born with
fully differentiated testes comprising the main cellular constituents [7], some key events take
place in postnatal life leading up to puberty. Firstly, the fetal Leydig cell population is replaced
by adult Leydig cells [8], and secondly, the germ cells exit mitotic arrest and develop within the
seminiferous tubules to the point of spermatogenesis during puberty [9]. Thus, although most
studies aimed at examining endocrine disrupting effects of chemicals on late-life male reproduc-
tive health, the juvenile stage is a sensitive period that warrants further scrutiny.
Data from the National Health and Nutrition Examination Survey study [10] and other
sources were used to identify the chemicals and their corresponding exposure levels in the
human population. We chose to combine 27 chemicals and expose the animals for 3-month to
represent chronic exposure. An additional two doses of 3- and 10-fold higher were also
included. The lowest dose was designed with the aim of obtaining rat plasma or urine concen-
trations approaching those reported in humans. Single congeners were in some cases selected
to cover chemical groups. Furthermore, doses were determined using linear extrapolation of
doses from high-dose animal studies. In other words, some assumptions where made that can
give rise to some uncertainty when extrapolating data for human relevance. Nevertheless, we
cautiously designate the mixture “a low-dose mixture”. After three months of exposure the ani-
mals were assessed for general pathology, metabolic changes, as well as more thorough histo-
logical and molecular analyses of affected organs.
Materials and Methods
Chemicals
Amixture comprising 27 chemicals was designed based on information on human exposure
levels according to the NHANES database (geometric means) [10] and other sources (Table 1).
Some chemicals were chosen to represent certain groups of chemicals: Acrylamide, to also rep-
resent the metabolite glycidamide; Bisphenol A to represent bisphenols; Perfluorooctanesulfo-
nic acid (PFOS) and PFNA to represent perfluorinated compounds; Mono-n-butyl phthalate
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to represent mono- and di-ester phthalates; PCB-153 to represent PCBs; TCDD to represent
dioxins; Benzo[a]pyrene to represent PAHs; PHIP and MeIQx to represent heterocyclic
amines. For each chemical, rat or human bioavailability studies were used to estimate the doses
needed for rats to reach a plasma or urine concentration similar to those reported in humans
according to the NHANES database and others. We assume that urinary or plasma levels are
linearly related to dose levels For mono-n-butyl phthalate, AHTN, PHIP and MeIQx, human
intake levels were used to assess doses to the rats and multiplied with a factor of 2.2 to account
Table 1. Chemicals included in the mixture.
Chemical (common name / /chemical
name)
CAS number Concentration measured in humans (reference) Dose in Low-dose
animal group (μg/kg
bw/day)
Acrylamide 79-06-1 5.4 nmol/L plasma [10] 4
Benzophenone-3 /oxybenzone 131-57-7 22.9 μg/L urine [10] 2.6
Bisphenol A 80-05-7 2.64 μg/L urine [10]. Alternatively a plasma concentration in the Hong
Kong population was 0.95 μg/L [12]
10
Triclosan 3380-34-5 13 μg/L urine [10] 5
Ortho-phenylphenol 90-43-7 0.5 μg/L urine [10] 0.06
trans-nonachlor 39765-80-5 0.11 ng/g serum [10] 0.35
p.p-DDE /
Dichlorodiphenyldichloroethylene
72-55-9 1.54 ng/g serum [10] 13
2.4.6-trichlorophenol 88-06-2 2.85 μg/L urine [10] 10
Chlorpyrifos 2921-88-2 1.77 μg/L urine of the metabolite TCPγ. [10] 0.4
3-phenoxybenzoic acid 3739-38-6 0.29 μg/L urine [10] 0.01
Arsenic 1327-53-3 8.3 μg/L urine [10] 1.2
Barium 10361-37-2 1.5 μg/L urine [10] 0.13
Cadmium 10108-64-2 0.41 μg/L blood [10] 0.1
Cesium 7647-17-8 4.4 μg/L urine [10] 0.48
Cobalt 7646-79-9 0.38 μg/L urine [10] 0.05
Lead 7758-95-4 0.80 μg/L urine [10] 16
Mercury 7487-94-7 0.44 μg/L urine [10] 3.5
Thallium 7791-12-0 0.18 μg/L urine [10] 0.3
PFOS / Perﬂuoro-octanesulfonic acid 111873-33-7 20.7 μg/L serum [10] 0.9
PFNA / Perﬂuoro-nonanoic acid 375-95-1 1.0 μg/L serum [10] 0.2
Mono-n-butyl phthalate 131-70-4 24.6 μg/L urine [10] 62
AHTN / 6-Acetyl-
1,1,2,4,4,7-hexamethyltetraline
1506-02-1 No data on human tissue concentrations. Values are based on intake
HERA (2004) data [13]
6.2
PCB 153 (covering the PCBs)
/Polychlorinated biphenyl 153
35065-27-1 0.17 ng/g serum [10]An alternative number is reported by Bakker
et al. [14]. Here seven indicator PCBs are present at 0.36 ng/g serum
20
TCDD (Dioxines) /
2,3,7,8-Tetrachlorodibenzo-p-dioxin
1746-01-6 2.6 ng/L serum (sum of four dioxins: HpCCD 155 fg/g serum; HxCCD
105 fg/g serum; OCDD 2230 fg/g serum; HpCDF 62 fg/g serum) [10]
0.034
Benzo[a]pyrene (PAHs) 50-32-8 6.3 μg/L urine(a sum of 10 PAHs: 2-hydroxyﬂuorene 304 ng/L;
3-hydroxyﬂuorene 134 ng/L; 9-hydroxyﬂuorene 267 ng/L;
1-hydroxynaphtalene 2680 ng/L; 2- hydroxynaphtalene 2470 ng/L;
1-hydroxyphenantrene 140 ng/L; 2-hydroxyphenantrene 54 ng/L;
3-hydroxyphenantrene 105 ng/L; 4-hydroxyphenantrene 23 ng/L;
1-hydroxypyrene 89 ng/L) [10]
0.4
PHIP / 2-Amino-1-methyl-6-phenylimidazo
(4,5-b)pyridine
105650-23-5 0.41 ng/ L (mean of 13 subjects, 24 h urine set to 1 L) based on
Wakabayashi et al. [15] [15][15]
0.1
MeIQx /2-Amino-3,8-dimethylimidazo
[4,5-f]quinoxaline
77500-04-0 22.5 ng/ L (mean of 13 subjects, 24 h urine set to 1 L) based on
Wakabayashi et al. [15]
0.05
Total dose 160
doi:10.1371/journal.pone.0162027.t001
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for the difference in metabolic rate between humans and rats (body surface area conversion)
[11]. The chemicals are presented in Table 1 and the calculations underlying the doses in Sup-
porting information (S1 Table). Chemicals were purchased from Sigma Aldrich except; benzo-
phenone-3 (AcrosGeel), Bisphenol A and DDE (LGC Standards), Triclosan (AlfaAesar.),
TCDD (AccuStandard), Benzo[a]pyrene (Lancaster), MeIQx and PHIP (Abcam).
Animal procedure
Animal experiments were carried out in accordance with the guidelines stipulated by the
National Food Institute’s Animal Welfare Committee. Ethical approval was given by the Dan-
ish Animal Experiments Inspectorate (Authorization no. 2012/561-188). The animals were
monitored twice daily for the duration of the exposure experiment. Clinical assessments
included general well-being, feed and water intake, as well as observation of presence and
appearance of feces. If an animal was to appear clinically sick based on the monitoring criteria,
considered highly likely to die within 24 h, or otherwise deemed unethical to keep alive, it was
to be humanely euthanized immediately. No unexpected deaths occurred during the experi-
ments, but animals from the High-dose group were prematurely euthanized as some animals
started to display poor clinical appearance before the end of the dosing period.
Four week-old male Wistar Hannover Galas rats were purchased from Taconic European and
allowed to acclimatize for two weeks. Animals were housed in pairs in Makrolon type III cages
(Bioscape) with Tapvei bedding (Tapvei) and ad libitum access to Altromin 1324 feed (Altromin)
and acidified tap water in bisphenol A-free bottles. Lights were on from 9 am to 9 pm. The tem-
perature was 22±1°C with a humidity of 55±5%. The rats were randomly assigned to the follow-
ing groups (n = 10 for each group): i) control group receiving vehicle, ii) Low-dose mixture
receiving in total 0.16 mg/kg bw/day, iii) Mid-dose mixture given in total 0.47 mg/kg bw/day and
iv) High-dose mixture given in total 1.6 mg/kg bw/day. The chemicals were administered orally
by gavage once daily using corn oil as vehicle for 14 weeks. The dose volume was 2 mL/kg bw.
Body weight, feed, water intake and overall clinical appearance were recorded during the experi-
ment. Blood samples (~0.2 mL) were drawn from the lingual vein in randomized order at day 30
and 66 (denoted day 60 in figures) for all animals. At the end of the experimental period, animals
were dosed 1½ h before being anaesthetized in CO2/O2 and decapitated in a randomized order.
Trunk blood was collected, kidney, liver, testicles, retroperitoneal fat pad, prostate, heart, adre-
nals, brain, pituitary and spleen were dissected and weighed, before being processed for histology
or other downstream experiments. Plasma was isolated from the blood samples by centrifugation
at 1,700 g for 10 min at 4°C and stored at -80°C until metabolomics and internal dose analyses.
A separate single-dose experiment was conducted to measure the relative excretion of
selected chemicals in urine samples collected over 24 h after excretion. Four week old male
Wistar Hannover Galas rats were housed in metabolic cages after having received a single dose
of vehicle (corn oil; control), Low- or Mid-dose as stipulated above. Each group consisted of 2
animals. The urine was continuously collected into vials on ice. Two additional ‘0’-control sam-
ples (~field blanks) consisting of 5 mL synthetic urine was collected to measure background
levels of chemicals. This was done by passing 2.5 mL synthetic urine through a metabolic cage
at 4 hours and repeated at 22 hours, then collected and processed as for the biological samples.
The urine was stored at -80°C until further analysis.
Animal body and organ weights were tested for normal distribution using the D’Agostino &
Pearson omnibus normality test using Graph Pad Prism V5 (Graph Pad, La Jolla, CA, USA).
Data were tested by ANOVA, or in case of no normal distribution, by the Kruskal-Wallis test.
Dunnett’s (ANOVA) or Dunn’s (Kruskal-Wallis) post tests were applied to determine the
effects of single treatment groups compared to controls.
Adverse Health Effects of a 27-Chemical Mixture
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Urinary excretion measurement
The uptake and subsequent excretion of benzophenone-3, triclosan, and mono-n-butyl phthal-
ate in 24 h urine samples were deconjugated by enzymatic hydrolysis and measured by isotope
diluted TurboFlow-LC-MS/MS as previously described [16,17].
Histology
Formaldehyde-fixed livers and kidneys were sectioned at 3 μm thickness and stained with
hematoxylin and eosin. Evaluation of sections was performed blinded to treatment groups. Liv-
ers were assessed for signs of hepatocellular fatty changes (macrovesicular changes with dis-
placement of the nucleus, microvesicular changes), localization of the changes (centrilobular,
midzonal, periportal or intermediate localizations) and severity of the vacuolar changes defined
as the distribution of changes in hepatocytes (scored from minimal to severe). Kidneys were
evaluated for hypertrophy of convoluted tubules. Scores for kidneys were i) no hypertrophy, ii)
slight hypertrophy, and iii) hypertrophic convoluted tubules.
Statistical analyses of histology scoring data were performed with SAS Enterprise Guide 6.1
using a Fisher’s exact test. When more than 2 score-levels were used, an overall Fisher’s exact
RxK test was used to assess the distribution of scores. Additionally, a Fisher’s 2xk test (includ-
ing all score-levels) was run to identify differences from controls in each exposure group. A 2x2
Fisher’s exact test was performed for dichotomous data (i.e. two score-levels, e.g. for presence
of microvesicular changes and presence of macrovesicular changes). As expected, no changes
were observed in controls, and a one-sided 2x2 Fisher’s exact test was performed for the pres-
ence of macrovesicular or microvesicular changes in hepatocytes.
Hormone measurements
Blood samples were analyzed for steroid hormone levels by LC-MS/MS as previously described1.
Rat hepatotoxicity gene array
The Rat Hepatotoxicity RT2 Profiler™ PCR Array (Qiagen; PARN-093ZE-4) was used to profile
expression of 84 genes related to hepatotoxicity. Tissue samples derived from 4 randomly cho-
sen livers each from control, Low- andMid-dose groups. The High-dose group was not included
as it was prematurely terminated, making direct comparisons unfeasible. Total RNA was
extracted from homogenized rat livers using the RNeasy Mini kit (Qiagen) including on-column
DNase I treatment. cDNA was synthesized from 1 μg total RNA using the recommended RT2
First Strand Kit (Qiagen). Samples were prepared for 384-well format and run on a 7900HT
Fast Real-Time PCR System (Applied Biosystems). Relative transcript levels were determined
by the comparative Ct-method using the Qiagen on-line Data Analysis Center. Data was nor-
malized with the geometric mean of four reference genes: Actb,Hprt1, Ldha and Rplp1.
RT-qPCR TaqMan analysis
The protocols were essentially as described previously [18], with 500 ng total RNA used to syn-
thesize cDNA. Samples derived from 4 randomly selected livers from each study group (con-
trol, Low- and Mid-dose) and were different from those used for the gene array analysis. cDNA
was diluted 1:20 and used at 3 μl per RT-qPCR reactions. TaqMan Gene Expression Assays
(Life Technologies) were: Abcc3 (Rn01452854), Actb (Rn00667869), Aldo1 (Rn00820577),
Car3 (Rn01461970), Cdkn1a (Rn01427989), Cyp1a2 (Rn00561082), Fmo1 (Rn00562945),
Nqo1 (Rn00566528), and Rps18 (Rn01428913). RT-qPCR assays were run on a 7900HT Fast
Real-Time PCR System (Applied Biosystems). Relative transcript abundance was calculated by
Adverse Health Effects of a 27-Chemical Mixture
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the comparative Ct-method using the reference genes Rps18 [18] and Actb (Qiagen). Statistical
comparisons were performed using unpaired, two-tailed Student’s t-test.
Metabolomics
The blood plasma analysis was conducted as previously described [19]. Phospholipids, the
non- polar fraction as well as the polar fraction were recovered. Metabolites were separated
using an Ascentis Express C8 HPLC column (Supelco) and measured using a Bruker maXis
time-of-flight mass spectrometer equipped with an electrospray ion source (Bruker Daltonics).
The samples were analyzed in both positive and negative ionization mode, and data obtained
as mass-to-charge (m/z) ratios with concomitant HPLC metabolite retention times. The Profile
Analysis 2.1 software package (Bruker Daltonics) was used for data analyses. Data buckets had
a time window of 60–720 s and an m/z ratio of 100–700 using the ‘find molecular feature’-algo-
rithm, including time alignment. Data noise was reduced using the software program R [20].
The raw intensity data were transferred to the online MetaboAnalyst server 7 [21], normalized
by sum and log-transformed. Pareto-scaling and Partial least squares (PLS) discriminant analy-
sis were performed collectively for all data sets. Discriminatory metabolites were determined
by use of a false discovery rate-adjusted p-value of 0.05 following ANOVA analysis. Raw non-
transformed or log-transformed data of these metabolites were tested for normal distribution
using the D’Agostino & Pearson omnibus normality test. Data were then tested by ANOVA or,
if not normally distribution, by the Kruskal-Wallis test. Dunnett’s (ANOVA) or Dunn’s (Krus-
kal-Wallis) post tests were applied to determine the effects of single treatment groups.
Attempts to identity single metabolites was done by use of the Human Metabolome Database
10 [22] searching the accurate mass of the metabolites. In addition, adducts or fragments (e.g.
plus Na+ or minus H2O) at identical HPLC retention times were considered.
Results
Body weight, clinical appearance, lethality and organ weights
The average body weight of animals in the High-dose group was approximately 20% lower
than that of the control group on exposure day 71 (Fig 1). As this could indicate severe toxicity,
the animals from the High-dose group were euthanized on day 71, 19 days prematurely (One
animal from the High-dose group was euthanized already on day 60 due to a poor clinical
appearance). There was also a tendency towards reduced body weight in the Low- and Mid-
dose groups compared to controls, albeit not statistically significant at the end of the exposure
period (Fig 2). Feed and water intake was lower for the High-dose group, but not different for
the Low- and Mid-dose groups relative to controls (data not shown). At the organ level, we
observed a significant increase in relative liver weight in both the Low- and Mid-dose groups
(Fig 2). Relative kidney and spleen weights were significantly increased in the Mid-dose, but
not Low-dose group (Fig 2). Organ weights were not measured for the High-dose group, as
these animals were euthanized prematurely.
Single dose experiment
Triclosan, benzophenone-3 and mono-n-butyl phthalate were measured in 24 hour urine sam-
ples collected after a single administration of no-dose (controls), Low- and Mid-dose. The con-
centrations of triclosan (Low-dose: 0.30 and 0.49 ng/mL; Mid-dose 7.03, 5.98 ng/mL),
benzophenone-3 (Low-dose: 5.0 and 11.2 ng/mL; Mid-dose 14.7 and 30.4 ng/mL) and mono-
n-butyl phthalate (Low-dose: 314 and 617 ng/mL; Mid-dose 816 and 1625 ng/mL) varied
between the two dosed rats in each dose group. However, after adjustment for individual rat
Adverse Health Effects of a 27-Chemical Mixture
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weight, volume of urinary excretion and osmolality, the urinary recoveries of benzophenone-3
and mono-n-butyl phthalate were calculated to be 7–10% and 19–23%, respectively in both the
Low- and Mid-dosed rats. Only 0.2% (Low-dose) and 1–2% (Mid-dose) of triclosan was
excreted in urine. In control rats the concentrations in 24 hour urine samples were below LOD
Fig 2. Relative organ weights of animals.Relative weights of liver, kidney and spleen in rats administered Low- and Mid-dose of the 27 chemical
mixture. In the Mid-dose group, all three organs showed significantly increased weight, whereas only the liver was significantly larger in the Low-dose
group. N = 10 for each group, Data are presented as Mean ± SEM. Statistical tests were one-way ANOVA with Dunnett’s post-test for normal
distributed data or with Kruskal-Wallis with Dunn’s post-test for data that were not normal distributed (*p <0.05, **p<0.01 and ***p<0.001).
doi:10.1371/journal.pone.0162027.g002
Fig 1. Absolute body weight of rats following exposure to a 27-chemical mixture. Juvenile rats were given an oral
daily dose of a 27 chemical mixture for 3 months. Animals in the High-dose group were euthanized prematurely (day 71)
due to poor clinical appearance. No significant differences in body weight were observed in other dose groups compared to
control animals. Doses were: Low = 0.16 mg/kg/day; Mid = 0.47 mg/kg/day; High = 1.6 mg/kg/day. N = 10 for each group.
Data are presented as mean ± SEM.
doi:10.1371/journal.pone.0162027.g001
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for triclosan, 0.22 ng/mL for benzophenone-3, whereas a weak mono-n-butyl phthalate con-
tamination of 16.1 and 14.2 ng/mL was observed.
Histology
Since several livers showed enhanced lobular pattern at the macroscopic level, livers were eval-
uated histologically (Fig 3). Hepatocytic accumulations were observed in exposed animals.
Macro-vesicular changes in hepatocytes were evident in 9 out of 10 animals already at Low-
dose exposure. The rate of hepatocellular vacuolization was comparable in Mid- and High-
dose groups, but now also showing clear signs of both macro- and micro-vesicular changes
(Fig 3A and 3D). Micro-vesicular changes are suggestive of more severe hepatotoxicity and
were observed in the Mid- and High-dose groups only, with a greater incidence rate in High-
dose (40% of animals with p = 0.04 for the Mid-dose and 67% of animals with p = 0.003 for the
High-dose in a one-sided 2x2 Fisher’s exact test; Fig 3A). Livers with micro-vesicular changes
in the High-dose group often displayed ballooning of hepatocytes in periportal areas or
changes occupying most of the lobules (diffuse). The severity of vacuolization increased with
Fig 3. Type (A) and severity (B) of histological changes of the liver. A, Significant hepatocellular vacuolization was observed in livers in all dose
groups, with only macrovesicular changes observed in Low-dose, but microvesicular changes appearing already in Mid-dose and occurring more
frequently in High-dose. B, Severity of hepatocellular vacuolization, including both macrovesicular and microvesicular changes, increased with increasing
dose. C, Liver from control rat. D, Liver fromMid-dose group showing moderate vacuolization with macrovesicular (arrowheads) and microvesicular
(arrows) changes. N = 9–10/group. ***p<0.001 in Fisher’s exact 2xk test. Scale bar = 100 μm.
doi:10.1371/journal.pone.0162027.g003
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increasing dose, with more hepatocytes being affected (Fig 3B). This was evident by a shift
from minimal or mild in 67% and 50% of animals with vacuolated hepatocytes (macro- and/or
micro-vesicular) in Low- and Mid-dose groups respectively, to 88% of affected animals in the
High-dose group with moderate to severe vacuolization (Fig 3B). Hepatic changes were pre-
dominantly localized to the mid-zonal area of the lobules.
Kidney histology from the same animals was evaluated, but revealed no significant
changes in the Low-dose group relative to control animals (data not shown). In the Mid-dose
group, an increase in the incidence of slight hypertrophy of convoluted tubules in the cortex
(6 out of 10 animals) was observed (p = 0.057 in a 2-sided 2x2 Fisher’s exact test). In a subset
of animals from the prematurely euthanized High-dose group, 5 out of 6 kidneys displayed
severe hypertrophy of convoluted tubules (data not shown, p = 0.0002 in a 2-sided 2xk Fish-
er’s exact test).
Steroid hormone levels
Steroid hormone levels were analyzed in blood serum collected after 90 days of chemical expo-
sure. Four hormones were measured; androstenedione, testosterone, corticosterone and pro-
gesterone. Although we observed a trend towards elevated testosterone levels in Mid-dose
animals (Fig 4), we observed no statistically significant changes in any of the four hormones in
Low- or Mid-dose animals compared to controls.
Fig 4. Steroid hormone levels. Steroid hormone levels in serum of rats administered a 27-chemical mixture for 90
days. The levels of androstenedione, testosterone, corticosterone or progesterone were quantified by LC-MS/MS.
No statistically significant changes in hormone levels were observed, but testosterone showed a strong trend
towards elevated levels in the Mid-dose group relative to controls. N = 10 for each group. Data are presented as
mean ± SEM.
doi:10.1371/journal.pone.0162027.g004
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Hepatotoxicity gene expression array
Next we performed a hepatotoxicity 84-gene expression array on four liver samples from each
group (control, Low- and Mid-dose). As depicted in Fig 5A, animals from the Low-dose group
displayed altered gene expression at a conservative cut-off value of 2-fold change in transcript
abundance. Particularly, a down-regulation of Car3 and up-regulation of Gadd45a and Nqo1 is
indicative of hepatotoxicity, whereas dysregulation of Abcc3 can indicate cholestasis. A similar
profile was observed in the Mid-dose group, but with a slightly higher fold expression relative
to control, and with more genes displaying statistically significant changes in relative transcript
abundance (Fig 5B). For instance, two additional markers for hepatotoxicity, Pla2g12a and
Fmo1 were up- and down-regulated, respectively. There was also a significant down-regulation
of Abcb1a, an additional marker for cholestasis, as well as Srebf1, indicative of steatosis. Also,
Fig 5. Relative mRNA levels of hepatotoxicity marker genes. A,B) Scatter-plots of differentially expressed hepatotoxicity
biomarker genes in livers of control animals and animals from Low- and Mid-dose mixture groups. Relative fold expression was
determined from average transcript abundance across groups (n = 4 from each group). Genes up-regulated more than 2-fold are
highlighted in red and genes down-regulated more than 2-fold highlighted in green. Dashed lines indicate two-fold change in
expression relative to controls (whole line). C) The targeted gene array was verified by TaqMan RT-qPCR assays on 7 genes
across the animal groups (n = 4 from each group). The identified up-regulated genesNqo1, Abcc3 andCyp1a2, unaltered gene
Aldo1, and down-regulated genesCdkn1a, Fmo1 andCar3 all showed similar expression profile as from the array. Statistical
significance was determined by two-tailed, unpaired Student’s t-test (*p <0.05, **p<0.01 and ***p<0.001).
doi:10.1371/journal.pone.0162027.g005
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the necrosis marker Cdkn1a was significantly down-regulated in the Mid-dose group. Finally,
Cyp1a1 showed the highest degree of up-regulation, both in Low- and Mid-dose groups (Fig
5A and 5B).
To verify the gene array data, we performed RT-qPCR experiments on additional liver sam-
ples obtained from the three groups; control, Low- and Mid-dose (Fig 5C). We selected three
genes each that displayed up- or down-regulation in the array, namely Nqo1, Abcc3, Cyp1a2
and Cdkn1a, Fmo1, Car3, as well Aldo1 which did not show a significant change in transcript
abundance. All seven genes were verified to display a similar expression profile between the
biological samples as was shown with the targeted gene array.
Metabolomics
Blood samples were obtained throughout the experiment to allow for a temporal metabolomics
analysis at 30, 60 and 90 days after initiation of exposure. As animals from the High-dose
group were euthanized at 70 days, analyses from this group were only performed at 30 and 60
days and also excluded from the PLS-DA scores plots (Fig 6). Otherwise, a clear separation of
control, Low-and Mid-dose groups were observed in the positive mode for phospholipids, neu-
tral lipids and for the polar fraction. In all fractions, the control group was located to the left as
compared to the Low- and Mid-dose groups in the scores plots. For the polar fractions ana-
lyzed in negative mode, the separation was less clear (data not shown). To identify metabolites
that were differently regulated in response to chemical exposure we used a false discovery rate
corrected ANOVA in the Metaboanalyst web-tool with subsequent evaluation of raw data in
Graph Pad Prism. By searching the HMDB database for exact mass of metabolites from the
lipid and polar fractions alongside searches for fragments and adducts, putative identities of
metabolites were obtained (S2 Table).
Seven phosphatidylcholines were significantly regulated between various test groups and/or
exposure duration (Fig 7). Phosphatidylcholine (18:0) was increased at all time points in Mid-
dose, but decreased at 30 days and increased at 60 days with the High-dose. A similar expres-
sion pattern was observed for phosphatidylcholine (20:4) and phosphatidylcholine (22:6).
Phosphatidylcholine (14:0, 16:0, 16:1) and phosphatidylcholine (18:2) were all decreased in
High-dose animals at 30 days. Similarly, six metabolites from the neutral lipid fraction were
found to be significantly changed between groups and exposure periods (Fig 8). For the neutral
lipids no decreases were observed, but several metabolites were increased in response to chemi-
cal exposure. Practically all of the neutral lipids showed elevated levels after 30 days, albeit not
all statistically significant, and all but the proposed metabolite 4α-Carboxy-5α-cholesta-8-en-
3β-ol also in the Low-dose group. After 60 and 90 days the effects were less severe, and for the
unidentified lipids at 285.243 and 257.248 m/z, as well as monoglyceride 18:0, any effects were
negligible. The unidentified lipid at 447.383 m/z showed strongest increase in blood plasma
from the Mid-dose animals. The monoglyceride 18:0 fragment was verified by identifying its
acyl group fragment by MS/MS. Finally, metabolites from the polar fractions were typically
decreased relative to control (Fig 9). One exception was metabolite (127.040 m/z), which was
significantly increased after 60 days of exposure. Monoglyceride 14:0 was verified by the pres-
ence of Na+, H2O and acyl chain fragments, and was found to be decreased by Mid-dose at 90
days.
Discussion
In this study, we aimed to test if a low-dose mixture containing 27 environmental chemicals
left an adverse pathophysiological footprint in juvenile male rats. Exposing juvenile male rats
for 3 months to a mixture of 27 chemicals resulted in liver injury. A dose-dependent increase
Adverse Health Effects of a 27-Chemical Mixture
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Fig 6. PLS DA plots of metabolomics data show that the Low-dose has an overall effect on the metabolome.
Plasma from rats administered Low- and Mid-dose for 30, 60 or 90 days was separated into a phospholipid, a neutral lipid
and a polar fraction. These were separated by HPLC and analyzed by MS using the positive ionization mode (positive
mode) and for the polar fraction also the negative mode. A clear separation of experimental groups is evident shown as a
dose-dependent effect on the metabolome of the mixture and as well as a low dose effect on the metabolome. Red
groups are control, green are Low-dose and blue are Mid-dose. Numbers given in brackets at the axes designate the
percentages of variation accounted for by the specific principal components (PCs).
doi:10.1371/journal.pone.0162027.g006
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Fig 7. Phospholipid levels were altered by the mixture.Metabolome analysis of rat blood after 30, 60 or 90 days of
exposure to a 27-chemical mixture. N = 10 for each group and data are means ± SEM. The data were statistically tested
as the exposure groups versus controls at each respective time point. The tests were one-way ANOVA with Dunnett’s
post-test for normal distributed data or with Kruskal-Wallis with Dunn’s post-test for data that were not normal distributed
(*p <0.05, **p<0.01 and ***p<0.001). The identities of all phosphatidylcholines were verified by the presence of the
phosphatidylcholine fragment 184.07 m/z in the MS/MS analysis.
doi:10.1371/journal.pone.0162027.g007
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Fig 8. Neutral lipid metabolites were altered by the mixture.Metabolome analysis of rat blood after 30, 60 or 90 days of exposure.
N = 10 for each group, Data are presented as mean ± SEM. The data were statistically tested as groups versus controls at each
respective time point. The tests were one-way ANOVA with Dunnett’s post-test for normal distributed data or with Kruskal-Wallis with
Dunn’s post-test for data that were not normal distributed (* designates p <0.05, **p<0.01 and ***p<0.001).
doi:10.1371/journal.pone.0162027.g008
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in liver weights and histological changes were evident, indicative of hepatic steatosis which was
further verified by a liver toxicity gene array. Changes to the metabolome were also detected in
animals from the Low-dose group, potentially associated with hepatotoxicity.
Initially we analyzed the animals for various endpoints that we thought could be affected
based on previous knowledge of individual chemicals. For instance, the chemical mixture
included several reported endocrine disrupting chemicals such as PFNA [1], BPA [23] and
phthalates [24]. Although endocrine disruptors often are most detrimental to male reproduc-
tive parameters during in utero development, we predicted some disrupting effects to hormone
levels or testis maturation. Thus we measured testicular weight and selected steroid hormones.
Surprisingly, we did not detect any significant changes in the serum levels of testosterone,
androstenedione, corticosterone or progesterone. There was a trend towards elevated testoster-
one, but the data were not sufficiently robust to conclude on any real effects. Testis weights
were also unchanged in the exposed animals and we conclude that the chemical mixture did
not adversely affect these endpoints following three months of chronic exposure. Even though
single chemicals included in the mixture are known to affect these endpoints, we observed no
mixture effects at the selected doses and life-stage.
The three organs that showed increased weight in exposed animals were the spleen, kidney
and liver. They were all affected in a dose-dependent manner and significantly larger in Mid-
dose group compared to controls, with the liver also larger in the Low-dose group. Although
kidneys and spleens displayed slight hypertrophy at higher exposure levels, we decided to look
more closely at the livers only, as the overall aim of the study was to detect adverse effects by
low-dose chemical exposure. The livers showed clear signs of steatosis, evident by excessive
lipid accumulation in hepatocytes, with dose-dependent increase in severity and significant
changes observed already at the lowest dose.
Signs of general hepatotoxicity were also evident at the transcriptional level. Several marker
genes were dysregulated, including Nqo1, Cyp1a2 and Fmo1. Nqo1 encodes an antioxidant pro-
tection enzyme that is often up-regulated in livers of rodents exposed to hepatotoxicity-induc-
ing chemicals and a strong indicator of liver injury [25][26]. So too, Cyp1a2, an Aryl
hydrocarbon receptor (AHR)-responsive hepatic CYP gene, is a well-established liver marker
for adaptive metabolic response to xenobiotics, likely serving to protect against hepatocellular
damage and inflammation [27]. The flavin-containing monooxygenase encoding gene Fmo1,
however, was down-regulated in the Mid-dose group. FMOs are known to metabolize a broad
spectrum of foreign chemicals [28]. Thus the down-regulation in this study was surprising, but
may indicate a compensatory mechanism reflecting increased enzymatic activities. Interest-
ingly, loss of Fmo1 in mice was recently shown to result in a lean phenotype in mice, thus being
involved in the regulation of energy homeostasis [29]. We also observed a lower body weight in
exposed animals. But whether there is a causal link between down-regulation of Fmo1 and loss
of body weight in our study cannot be determined.
We also performed an extensive metabolomics analysis of plasma collected at various times
during the cause of the experiment. Metabolomics PLS plots suggested that the metabolome
was changed already in the Low-dose group, with a more marked affect in the Mid-dose group.
Effects were evident for phospholipids, neutral lipids and the polar fraction (for the positive
ionization mode). Such changes in lipid homeostasis can be associated with liver toxicity, as
the liver is a central organ in the synthesis and metabolism of these lipids. That is, the changes
to the metabolome may simply reflect altered liver function [30]. In fact, altered lipid metabo-
lism is a common response to chemical exposure [31][32] and it has been demonstrated that a
stress-response to chemicals can lead to an increase in carbohydrate metabolism, subsequently
causing alterations in lipid metabolism [32].
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Fig 9. Polar metabolites were altered by the mixture.Metabolome analysis of rat blood after 30, 60 or 90 days of exposure.
N = 10 for each group, Data are presented as Mean ± SEM. The data were statistically tested as groups versus controls at each
respective time point. The tests were one-way ANOVA with Dunnett’s post-test for normal distributed data or with Kruskal-
Wallis with Dunn’s post-test for data that were not normal distributed (*p <0.05, **p<0.01 and ***p<0.001).
doi:10.1371/journal.pone.0162027.g009
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We observed general changes to the levels of phosphatidylcholines, with longer-chained
phosphatidylcholines (phosphatidylcholine:18/20/22) typically increased, albeit a general
decrease was observed at High-dose after 30 days of exposure for shorter chained phosphati-
dylcholines (phosphatidylcholine:14/16). Notably, this decrease at 30 days appears to be cor-
rected already at 60 days of exposure for most phosphatidylcholines, suggesting that the body
is capable of compensating for this early effect. The phosphatidylcholines are building blocks
for cell membranes and participate in signal transduction [33]. Thus the observed changes in
phosphatidylcholines indicate that these parameters were affected in the rats.
The neutral lipid fraction was also disturbed as illustrated by changes in proposed metabo-
lites such as monoglyceride 14:0 and the acyl fragment of monoglyceride 18:0. Monoglycerides
have been shown to participate in signalling transduction [34] but changes in these could also
reflect general disturbance to lipid metabolism and thus be linked to the histologically observed
steatosis. The proposed neutral lipid metabolite, 4α-Carboxy-5α-cholesta-8-en-3β-ol was
found to be increased, indicating a disturbance in cholesterol biosynthesis [22]. A decrease of
the proposed metabolite 3α,7α-dihydroxy-5β-cholestane in the polar fraction indicates that
there is a dysregulation of bile acid synthesis [35].
It is notable that the prevalence of hepatic steatosis in the United States is now 20–40%
[36,37]. This is a high incidence rate that could be partially attributed to an ever-increasing
chemical burden [38]. In this study, we have shown clear signs of liver toxicity at the lowest
exposure dose of the 27-chemical mixture; effects we deem unlikely to be the result of a single
compound. It has been suggested that the Pareto’s rule, which states that 20% of the causal fac-
tors determine 80% of the effects, may apply also when determining the drivers of a mixture
effect [39]. Regarding the constituents of our chemical mixture in relation to liver toxicity, four
compounds could be flagged as such potential contributors to the liver toxicity: arsenic, bisphe-
nol A, PCB and TCDD.
We observed signs of hepatotoxicity already in the Low-dose group, and we suggest that the
accumulated dose of these four chemicals may be the drivers of the hepatotoxicity observed fol-
lowing prolonged exposure. Arsenic has been shown to increase liver peroxidation and abso-
lute organ weight following exposure to 0.02 mg/kg bw/day for 60 days [40]. In our exposure
regimen of 30 days, the arsenic dose in the Low-dose group was 20-fold lower, thus unlikely to
have caused the observed liver toxicity on its own. Exposure to bisphenol A at 5 μg/kg bw for
10 weeks induced fat deposition in rat liver [41], whereas perinatal exposure to 50 μg/kg bw/
day induced increased apoptosis in rat livers [42]. Our Low-dose of 10 μg/kg bw/day can thus
be speculated to contribute to the observed liver toxicity. PCB153 has been shown to cause
liver injury in mice following exposure to 195 μg/kg bw/day for 28 days, which gives an accu-
mulated dose of 5.4 mg/kg bw [43]. In comparison, our accumulated Low-dose was 1.8 mg/kg
bw (20 μg/kg bw/day). Moreover, in a subchronic rat toxicity study, PCB153 induced histologi-
cal liver changes with a NOAEL of 34 μg/kg bw/day [44]. Thus, it is unlikely that our PCB153
dose induced the observed liver effects on its own. Finally, TCDD, has been reported to cause
liver toxicity following exposure to 100 ng/kg bw/day for 13 weeks, resulting in an accumulated
dose of 6.5 μg/kg bw [45]. Our accumulated dose following 3 month of exposure was estimated
at 0.66 μg/kg bw (when taking the half-life and non-first order kinetics into account [46]). In
another study [45], a dose of 10 ng/kg bw/day reportedly did not result in any adverse liver
effects after 3 months of exposure, whereas a dose of 100 ng/kg bw/day did. Our Low-dose falls
between these two doses, and therefore it cannot be excluded that TCDD in the present study
contributes to the observed liver toxicity (or other adverse effects) in juvenile male rats. Taken
together we deem it likely that it was the combined insult of these 4 contaminants in the entire
mixture that adversely affected the liver.
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We found that a low-dose mixture of 27 chemicals at a combined dose of 0.16 mg/kg bw/
day left an adverse footprint in juvenile male rats. The mixture was designed to represent a
combined dose approaching human exposure levels and we propose that our results show that
the combined environmental load of a large number of chemicals can pose a risk to the general
population. A few previous studies also support this notion. For instance, PFNA exposure as
low as 12.5 μg/kg bw/day for 14 days induces adverse effects, both alone and when co-adminis-
tered with a mixture of 14 environmental chemicals [1]. Others have found low-dose effects
from mixtures on natural killer cell lytic activity [2], prostate inflammation in rats following
exposure to an atrazine metabolite mixture at a dose of 0.09 mg/kg bw/day [3], and blood cell
count changes in mice after exposure to a mixture of pesticides at doses derived from the
acceptable daily intake levels in humans [4]. Changes to the blood cell count, as well as hemo-
globin concentrations in mice following exposure to a mixture of 4, 5 and 8 μg/kg bw/day of
atrazine, endosulfan and chlorpyrifos, respectively, has been reported [5], which support the
observations from Merhi and co-workers [4]. Finally, additive effects of thyroid disrupters at a
dose based on the environmental background has been reported in rats [6]. Hence, adverse
effects can be induced when approaching human relevant levels of exposure. An important
question to consider, however, is whether the chemical doses used in the present study were
appropriate to obtain plasma levels comparable to human exposure.
To overcome the immense challenge of designing a chemical mixture study representative
of real-life exposure to hundreds, if not thousands, of compounds simultaneously, we opted to
use a total of 27 compounds, where some congeners were dosed to represent the combined bur-
den of a chemical group, for instance BPA as a proxy for bisphenols in general. This approach
has some inherent problems though, including the fact that individual chemicals, despite
belonging to the same class of compounds, not necessarily have the same biomolecular or cellu-
lar effect. Also, doses were determined using linear extrapolation of doses from high-dose ani-
mal studies. The urine and plasma concentrations are not necessarily linearly affected across
the used dose-ranges, thus overall effect data must be viewed in light of these uncertainties
Another important consideration is that our calculations were based on administration of
single chemicals to animals. Thus, potential chemical toxicokinetic interactions causing indi-
vidual ADMEs to change during prolonged exposure are not accounted for, and could lead to
higher or lower plasma concentrations than expected. To analyze the minimum amount of
chemicals the rats were exposed to during the main study, a simple excretion experiment was
performed. After a single dose of Low- and Mid-dose mixture, the concentration of a subset of
chemicals was analyzed in 24 hour urine. At Low-dose, the urinary concentrations from two
individual rats were 0.3/0.49 ng/mL (μg/L) for triclosan and 5.0/11.2 ng/mL for benzophe-
none-3. These are lower than the human urine levels reported in NHANES, which are 13 and
22.9 μg/L for triclosan and benzophenone-3, respectively. For mono-n-butyl phthalate, we
measured urine levels of 314/617 ng/mL, which are higher than the human urinary level of
24.6 μg/L urine reported in NHANES 2009. These data indicate that our initial calculations
were reasonable, but failed to exactly predict internal dose levels for all the chemicals. However,
the dose recovery in urine for triclosan (~1.5%), benzophenone-3 (~8.5%) and mono-n-butyl
phthalate (~19%) were quite low and indicate that the majority was accumulated in the rats,
excreted in feces or as other metabolites in urine. When calculating the excreted dose per kg
body weight, the rats excreted 0.08, 0.22 and 11.8 μg/kg bw/day of triclosan, benzophenone-3
and mono-n-butyl phthalate, respectively after a single Low-dose and 0.23, 0.66 and 35 μg/kg
bw/day of triclosan, benzophenone-3 and mono-n-butyl phthalate, respectively after a single
Mid-dose. Thus, the rats excreted the three chemicals at similar levels as children and adoles-
cents in the general Danish population [17,47], where the daily mean excretion were measured
at 0.030, 0.034 and 2.5 μg/kg bw/day, and the observed maximum levels were about 1000, 100
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and 10 times higher for triclosan, benzophenone-3 and mono-n-butyl phthalate, respectively.
Taken together these aspects of metabolism and dose extrapolations caused us to cautiously
denote our mixture as “low-dose”, but still based on human exposure levels.
Of final note, we did not apply risk assessment-based safety factors that are commonly done
in animal studies. Such factors are typically in the order of 100-fold to account for animal-to-
human extrapolation, as well as inter-individual differences. We also note that humans are
likely exposed to thousands of chemicals simultaneously, not all being covered by the 27 chem-
icals included in this study. Based on this we suggest that the current findings raise concerns
that the current chemical burden can pose a risk to the general population. We suggest
increased emphasis on safety margins to protect humans against environmental chemicals.
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